We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+10.21%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$269M
AUM Growth
+$62.5M
(+30%)
Cap. Flow
-$58.3M
Cap. Flow
% of AUM
-21.7%
Top 10 Holdings %
Top 10 Hldgs %
34.36%
Holding
139
New
24
Increased
37
Reduced
15
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Photronics
PLAB
|
+$4.08M |
| 2 |
PDF Solutions
PDFS
|
+$3.72M |
| 3 |
CYBE
Cyberoptics Corp
CYBE
|
+$3.23M |
| 4 |
X4 Pharmaceuticals
XFOR
|
+$2.8M |
| 5 |
PDS Biotechnology
PDSB
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cohu
COHU
|
+$6.92M |
| 2 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$4.19M |
| 3 |
Rimini Street
RMNI
|
+$2.49M |
| 4 |
Nuvve Holding Corp
NVVE
|
+$1.93M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.01% |
| 2 | Healthcare | 12.43% |
| 3 | Industrials | 3.3% |
| 4 | Consumer Discretionary | 3.05% |
| 5 | Financials | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
1
DELISTED
Emcore Corp
EMKR
| $7.32M | 2.72% |
79,371
| – | – |
|
|
DZSI
2
DELISTED
DZS Inc. Common Stock
DZSI
| $5.25M | 1.95% |
252,752
+82,634
| +49% | +$1.43M |
|
|
GRTX
3
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $4.61M | 1.72% |
469,174
+254,932
| +119% | +$2.07M |
|
4
Aviat Networks
AVNW
$262M
| $4.55M | 1.69% |
138,974
| – | – |
|
5
Aspen Aerogels
ASPN
$387M
| $4.39M | 1.63% |
146,687
| – | – |
|
|
6
PDS Biotechnology
PDSB
$38.1M
| $4.38M | 1.63% |
+348,703
| New | +$2.72M |
|
|
CYBE
7
DELISTED
Cyberoptics Corp
CYBE
| $4.27M | 1.59% |
+104,140
| New | +$3.23M |
|
|
8
Photronics
PLAB
$1.79B
| $4.12M | 1.53% |
+311,669
| New | +$4.08M |
|
|
9
PDF Solutions
PDFS
$2.13B
| $3.78M | 1.41% |
+207,743
| New | +$3.72M |
|
|
OIIM
10
DELISTED
02Micro International
OIIM
| $3.35M | 1.25% |
465,169
| – | – |
|
|
THER
11
DELISTED
THERATECHNOLOGIES INC COM
THER
| $3.27M | 1.22% |
851,413
| – | – |
|
|
ADMS
12
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.12M | 1.16% |
590,730
+52,335
| +10% | +$271K |
|
13
Cardlytics
CDLX
$21M
| $3.08M | 1.14% |
2,425
+1,012
| +72% | +$1.14M |
|
14
Carvana
CVNA
$43.3B
| $3.04M | 1.13% |
50,445
+24,530
| +95% | +$1.33M |
|
15
Annovis Bio
ANVS
$70.6M
| $2.9M | 1.08% |
33,834
+3,866
| +13% | +$179K |
|
16
SCYNEXIS
SCYX
$37M
| $2.52M | 0.94% |
+42,891
| New | +$2.71M |
|
17
Silicom
SILC
$228M
| $2.52M | 0.94% |
57,319
+11,892
| +26% | +$514K |
|
|
AVYA
18
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.48M | 0.92% |
92,279
| – | – |
|
19
Puma Biotechnology
PBYI
$406M
| $2.4M | 0.89% |
261,610
+34,852
| +15% | +$353K |
|
|
ENV
20
DELISTED
ENVESTNET, INC.
ENV
| $2.36M | 0.88% |
31,120
+19,392
| +165% | +$1.43M |
|
|
21
X4 Pharmaceuticals
XFOR
$363M
| $2.17M | 0.81% |
+11,156
| New | +$2.8M |
|
22
OneMain Financial
OMF
$6.9B
| $2.16M | 0.8% |
36,066
+11,635
| +48% | +$659K |
|
23
Booking.com
BKNG
$138B
| $2.04M | 0.76% |
23,350
+11,825
| +103% | +$1.1M |
|
|
FOCL
24
EDAP TMS S.A.
FOCL
$226M
| $2.01M | 0.75% |
283,368
+28,550
| +11% | +$207K |
|
|
BWAY
25
Brainsway
BWAY
$641M
| $1.82M | 0.68% |
357,200
| – | – |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Worth Venture Partners held 139 positions worth $269M, up 30% from $206M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Worth Venture Partners withdrew a net $58.3M in Q2 2021, closing 24 positions and reducing 15 holdings. Its most notable exit was Cohu, an estimated $6.92M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Worth Venture Partners opened a new position in Photronics worth $4.12M.
- Worth Venture Partners's largest Q2 2021 buy was Photronics: 311,669 shares worth $4.12M.
- Worth Venture Partners added most to Galera Therapeutics, Inc. Common Stock in Q2 2021, an estimated $2.07M increase.
- Worth Venture Partners's biggest Q2 2021 reduction was Allot, cutting an estimated $346K.
- Worth Venture Partners fully exited Cohu in Q2 2021, selling an estimated $6.92M.
- Worth Venture Partners's ten largest holdings make up 34% of its $269M portfolio in Q2 2021.
- Worth Venture Partners opened 24 new positions and closed 24 in Q2 2021.
- Worth Venture Partners's portfolio value rose 30% quarter-over-quarter to $269M.
Based on Worth Venture Partners's 13F filing for Q2 2021, filed 16 Aug 2021.